CONTINUUM OF CARE FOR ACUTE CORONARY SYNDROME: OPTIMIZING TREATMENT FOR STEMI AND NSTE-ACS

CONTINUUM OF CARE FOR ACUTE CORONARY SYNDROME: OPTIMIZING TREATMENT FOR STEMI AND NSTE-ACS

In this EMCREG-International Monograph you will find a detailed discussion regarding the treatment of this important disease entity, acute coronary syndrome (ACS), which impacts millions of patients across the United States each year. This is a “state of the art” Monograph for emergency physicians, cardiologists, and hospitalists which provides the evidence basis for the optimal approach to treating ACS.

Read More

ADVANCING THE STANDARD OF CARE - CARDIOVASCULAR AND NEUROVASCULAR EMERGENCIES (2008)

ADVANCING THE STANDARD OF CARE - CARDIOVASCULAR AND NEUROVASCULAR EMERGENCIES (2008)

EMCREG–International is pleased to present this complimentary CME monograph providing up-to-date knowledge on the full spectrum of decision making and care for patients with acute coronary syndromes (ACS) including non-ST-segment elevation ACS (NSTE ACS) and ST-segment elevation myocardial infarction (STEMI), acute heart failure syndromes, pulmonary embolism and acute ischemic stroke.

Read More

THE EMCREG-INTERNATIONAL HYPERTENSION CONSENSUS PANEL: MANAGEMENT OF HYPERTENSIVE EMERGENCIES

THE EMCREG-INTERNATIONAL HYPERTENSION CONSENSUS PANEL: MANAGEMENT OF HYPERTENSIVE EMERGENCIES

This EMCREG-International Newsletter describe historical and physical examination findings crucial for the evaluation of end organ damage. Also provided are descriptions of hypertension associated with the following disease processes: Asymptomatic Hypertension, Acute Coronary Syndrome, Acute Heart Failure Syndromes, Neurological Emergencies, Cocaine or Amphetamine Induced Hypertension, and Aortic Dissection are provided with treatment recommendations. Through collaboration with colleagues from a variety of specialties, patients with hypertension can receive optimal therapy when presenting to any acute care setting.

Read More

DIRECT THROMBIN INHIBITORS IN NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROMES

DIRECT THROMBIN INHIBITORS IN NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROMES

For patients with non-ST-segment elevation acute coronary syndrome (NSTE ACS) presenting to the emergency department, appropriate anti-thrombotic and anti-platelet therapy is critical to optimize outcome. Unfractionated heparin is often given as an anti-thrombin in this setting, however, if suffers from a number of pharmacologic limitations including non-specific binding, the requirement for frequent monitoring of its anti-coagulant effect, and the formation of antibodies to the heparin/platelet factor 4/platelet complex which can cause heparin-induced thrombocytopenia (HIT) or heparin-induced thrombocytopenia thrombosis syndrome (HITTS). Low molecular weight heparins, also an indirect thrombin inhibitor, can be used without monitoring their anti-thrombin effects. Ease of use and effectiveness makes them a popular choice in the emergency setting.

Read More

ADVANCING THE STANDARD OF CARE - CARDIOVASCULAR AND NEUROVASCULAR EMERGENCIES (2006)

ADVANCING THE STANDARD OF CARE - CARDIOVASCULAR AND NEUROVASCULAR EMERGENCIES (2006)

EMCREG–International is pleased to present this complimentary 84-page CME monograph covering the proceedings of our satellite symposium at the ACEP Scientific Assembly in New Orleans, Louisiana. A number of important topics are covered in this monograph including management of non-ST-segment elevation and ST-segment elevation acute coronary syndrome (ACS), the CRUSADE Quality Improvement Initiative, decreasing time to treatment for ST-segment elevation myocardial infarction, direct thrombin inhibitors in ACS, acute decompensated heart failure care, the use of lactate as a marker for trauma and sepsis, point-of-care testing for cardiac biomarkers, the management of hypertension in acute neurovascular emergencies and advances in acute stroke care.

Read More

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION: A SILVER LINING ON THE HORIZON?

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION: A SILVER LINING ON THE HORIZON?

We are pleased to present this cutting edge clinical update report on cardiogenic shock (CS). Acute coronary syndromes and its complications are key components of emergency medicine practice. Specifically, CS is prevalent and occurs in roughly 10% of all cases of acute myocardial infarction (AMI). Despite numerous therapeutic advances in the treatment of cardiovascular disease, CS is still the leading cause of mortality among patients with AMI. This newsletter by Drs. Jeger, Anand and Hochman summarizes the classic CS paradigm and observations from the SHOCK trial challenging that paradigm.

Read More

ADVANCING THE STANDARD OF CARE - CARDIOVASCULAR AND NEUROVASCULAR EMERGENCIES (2004)

ADVANCING THE STANDARD OF CARE - CARDIOVASCULAR AND NEUROVASCULAR EMERGENCIES (2004)

EMCREG-International is pleased to present this educational monograph summarizing our 2004 ACEP Satellite Symposium on cardiovascular and neurovascular emergency care held in San Francisco. Topics presented included: Point-of-Care Testing for ACS in the ED; STEMI Time-to-Treatment; Chest Pain Center; Heart Sound Recording; Anti-Platelet and Anti-Thrombotics in ACS; BNP Consensus Panel; Stroke, and Intracerebral Hemorrhage. It is our hope that this material will provide emergency physicians with information necessary to help care for these seriously ill patients.

Read More

CARDIOVASCULAR and NEUROVASCULAR EMERGENCIES: IMPLICATIONS FOR CLINICAL PRACTICE (2003)

CARDIOVASCULAR and NEUROVASCULAR EMERGENCIES: IMPLICATIONS FOR CLINICAL PRACTICE (2003)

Patients presenting to the Emergency Department (ED) with chest pain remain a major clinical challenge. In the United States alone there are over eight million annual visits for this problem, resulting in over four million admissions. Nontraumatic chest discomfort remains the primary catalyst for ED evaluation of possible acute coronary syndromes, including unstable angina, non-ST-segment elevation myocardial infarction and ST-segment myocardial infarction. The diagnosis and treatment of congestive heart failure is also critically important to emergency physicians and other healthcare providers. The diagnosis of cerebrovascular disease is equally difficult, with up to one million patients presenting to the emergency department with stroke each year. Therefore, it is essential that emergency physicians remain on the forefront of state of the art diagnostic and treatment options involving the newest regimens for ACS, CHF, and stroke.

Read More

ACC/AHA 2002 Guidelines for the Management of Patients with Unstable Angina and Non-ST-Segment Elevation Myocardial Infarction: A SUMMARY FOR EMERGENCY PHYSICIANS

ACC/AHA 2002 Guidelines for the Management of Patients with Unstable Angina and Non-ST-Segment Elevation Myocardial Infarction: A SUMMARY FOR EMERGENCY PHYSICIANS

Current literature and clinical practice places a substantial emphasis on evidence-based medicine and evidence-based practice guidelines. In the year 2000, the American College of Cardiology (ACC) and American Heart Association (AHA) published comprehensive, evidence-based guidelines on the management of patients with unstable angina (UA) and non-ST-segment elevation myocardial infarction (NSTEMI). In 2002, these guidelines were updated due to the remarkable clinical advances in the care of these patients. Many aspects of these guidelines pertain directly to emergency physicians.

Read More

MODERN ADVANCES IN EMERGENCY CARDIAC CARE: EVOLUTION OF DIAGNOSTIC AND TREATMENT OPTIONS

MODERN ADVANCES IN EMERGENCY CARDIAC CARE: EVOLUTION OF DIAGNOSTIC AND TREATMENT OPTIONS

Patients presenting to the Emergency Department (ED) with chest pain remain a major

clinical challenge. In the United States alone there are over eight million annual visits for this problem, resulting in over four million admissions for possible acute coronary syndromes (ACS). The diagnosis and treatment of congestive heart failure (CHF) is also critically important to emergency physicians as 550,000 new cases present annually. Therefore, it is critical for the emergency physician community remain on the forefront of state of the art diagnostic and treatment options involving the newest regimens for ACS and CHF.

Read More